Meda’s product supply strategy is based on having proprietary production to achieve flexibility, combined with a significant proportion of contracted production in order to access new technology and achieve cost control.

In 2011, proprietary production generated about 40% of the total product supply. The remainder was procured from contracted manufacturing companies, mostly in Europe.

Meda has a well-developed network of contracted manufacturers who are continually evaluated in terms of quality, precision of delivery, and efficiency.
Contract manufacturing has increased in recent years; however, proprietary production remains a priority, not least to maintain technical know-how.

Meda’s proprietary manufacturing units:

MERIGNAC, FRANCE

The unit in Merignac, France, specializes primarily in the production of various fluids and solutions. Betadine is the main product made. The unit employs about 200 people.

COLOGNE, GERMANY

The manufacturing unit in Cologne, Germany, has capacity to manufacture many pharmaceutical formulations, both liquids and solids. The unit’s quality system meets European standards, as well as the strict requirements of Japanese and US drug authorities. Products made at the Cologne facility include the Novolizer asthma inhaler. The unit employs about 300 people.

DECATUR, ILLINOIS, USA

Meda’s manufacturing unit in Decatur, Illinois, USA, manufactures solid and liquid preparations and nasal sprays. This unit is approved by the FDA. The products made here include Soma, Astepro, and Astelin for the US market. The unit employs about 100 people.

LAKEWOOD, NEW JERSEY, USA

The Lakewood unit in New Jersey, USA, manufactures the MUSE product to meet global demand. The quality assurance system complies with FDA and European requirements. The unit employs about 70 people.